Showing posts with label patient specific. Show all posts
Showing posts with label patient specific. Show all posts

Thursday, April 4, 2013

TN Senate drops drug rule Bill would allow compounding with no prescription for a specific patient


The Tennessee Senate on Thursday overwhelmingly approved a measure that would allow pharmacists to compound drugs without having a prescription for a specific patient, a key safeguard that exists under current law.
The measure was approved on a 29-1 vote, without a word of dissent, after a presentation by Sen. Ferrell Haile, R-Gallatin, who is a pharmacist. Sen. Todd Gardenhire, R-Chattanooga, cast the only vote against the bill.
A House version of the bill, sponsored by Rep David Shepard, a Dickson Democrat, has cleared the House Health Committee and is awaiting a House floor vote. Shepard, like Haile, is a pharmacist.
The Tennessee Pharmacists Association pushed for adoption of the bill, which would create a loophole for hospitals and other health care providers to obtain compound drugs without having to identify a patient. It would do so by permitting compounders to ship drugs without having received a patient-specific prescription in cases when a product “is not commercially available.
Continue reading here 

Sunday, March 24, 2013

Washington State Board of Pharmacy Compounding State of Feb. 25, 2013 Re: Office Use and Patient Specific


Compounding Statement of February 25, 2013
Washington State Board of Pharmacy
Chris Humberson, R.Ph.
Executive Director



The Washington State Board of Pharmacy recently discussed pharmacy compounding and specifically WAC 246-878-020(4) at their Feb 21, 2013 meeting.  The board has always read (4) in conjunction with other subsections which specifically require a prescription for a compounded drug.  However, they agreed that (4), read independently, could allow a pharmacy to provide compounded products for a practitioner to administer to individual patients without a prescription for a specific patient.  Because this has clearly been the belief of some compounding pharmacies in Washington, the board decided it will honor this interpretation of the rule

The Board will continue the rule making process on compounding practices as voted on during their January 10, 2013 meeting to make sure pharmacy compounding is done under the appropriate standards to protect the health and safety of the people of Washington. They will involve all stakeholders in this process.

________________
Doreen E. Beebe
Program Manager
Washington State Board of Pharmacy
PO Box 47852
Olympia WA  98504-7852                                                           
Phone 360/236-4834
Fax 360/236-2901
Public Health – Always Working for a Safer and Healthier Washington.